✦ LIBER ✦

Alpha-interferon in chronic myelogenous leukaemia

✍ Scribed by Lalit Kumar; SubhashC. Gulati

Book ID: 118558711
Publisher: The Lancet
Year: 1995
Tongue: English
Weight: 484 KB
Volume: 346
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(95)91683-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of interferon alpha-induced cytog

Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia

✍ O. Kloke; N. Niederle; J. Y. Qiu; U. Wandl; T. Moritz; M. Nagel-Hiemke; I. Hawig 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

Several new approaches to improvement of

Several new approaches to improvement of alpha interferon therapy in chronic myelogenous leukaemia

✍ Shigetaka Asano; Hiromi Ogura; Kenzaburo Tani; Tokiko Inoue; Arinobu Tojo; Keiya 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 704 KB

Prognostic impact of interferon alpha-in

Prognostic impact of interferon alpha-induced cytogenetic remission in chronic myelogenous leukaemia: long-term follow-up

✍ O. Kloke; N. Niederle; B. Opalka; I. Hawig; S. Seeber; R. Becher 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

Response to the combined administration

Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia

✍ Kloke, Otto ;Becher, Reinhard ;Niederle, Norbert 📂 Article 📅 1987 🏛 Springer-Verlag ⚖ 332 KB

A previously untreated patient with benign phase chronic myelogenous leukaemia (CML) was treated with recombinant Interferon alpha-2b. Haematological remission was induced for a total of twelve months. Thereafter, the patient developed resistance to Interferon alpha manifested by an increase in leuc

Cytogenetic and breakpoint cluster regio

Cytogenetic and breakpoint cluster region (bcr) changes in chronic myelogenous leukaemia treated with low-dose alpha interferon

✍ Robin Aitchison; Ellen McSweeney; Les Butler; Leanne Weidemann; Adrian C. Newlan 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 119 KB

Combination therapy with interferon alph

Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia

✍ Ursula B. Wandl; Otto Kloke; Marianne Nagel-Hiemke; Thomas Moritz; Reinhard Bech 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB